Absin Bioscience Inc. announced that it has received CNY 71 million in a round of funding from returning investor Shanghai Universal Biotech Co.,Ltd. on February 20, 2022. The company has received funding through capital increase. The transaction is approved by the 3rd session of the company's 3rd directorate and the 2nd session of the company's 3rd supervisory board.